Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

Huang, Richard; Smith, Derek; Le, Catherine; Liu, Wen-Wei; Ordinario, Ellen; Manohar, Chitra; Lee, Michael; Rajamani, Jaya; Truong, Huan; Li, Jing; Choi, Cindy; Li, Jingchuan; Pati, Amrita; Bubendorf, Lukas; Buettner, Reinhard; Kerr, Keith; Lopez-Rios, Fernando; Marchetti, Antonio; Marondel, Ivonne; Nicholson, Andrew; Oz, Ayşim; Pauwels, Patrick; Penault-Llorca, Frederique; Rossi, Giulio; Thunnissen, Erik; Newell, Amy; Pate, Greg; Menzl, Ina

doi:10.5858/arpa.2019-0085-oa

Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

Atıf İçin Kopyala

Huang R. S. P., Smith D., Le C. H., Liu W., Ordinario E., Manohar C., ...Daha Fazla

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, cilt.144, sa.6, ss.735-741, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 144 Sayı: 6
Basım Tarihi: 2020
Doi Numarası: 10.5858/arpa.2019-0085-oa
Dergi Adı: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Public Affairs Index
Sayfa Sayıları: ss.735-741
İstanbul Üniversitesi Adresli: Evet

Özet

Context.-The ability to determine ROS1 status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with ROS1-positive lung adenocarcinoma.